๐Ÿ”Ž Trials Near Me

Home โ€บ Colon Cancer

Colon Cancer clinical trials recruiting in the U.S.

101 studies for Colon Cancer are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07059884

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07283939

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

RecruitingPhase 1
Ages 18 to 120 ยท All sexes ยท Updated Oct 2, 2026 ยท NCT06885697

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07529808

Family Communications After Genetic Testing

RecruitingHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07143487

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 2, 2026 ยท NCT07140679

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 1, 2026 ยท NCT06997497

PRE-ISPY Phase I/II Oncology Platform Program

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 30, 2026 ยท NCT05868226

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 30, 2026 ยท NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 29, 2026 ยท NCT07127874

Collection of Blood From Patients With Cancer

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00034216

Genomic Services Research Program

RecruitingObservational study
1 Month โ€“ 105 Years ยท All sexes ยท Updated Sep 28, 2026 ยท NCT02595957

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 22, 2026 ยท NCT06128551

Prehabilitation in High-risk Oncologic Surgery

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 21, 2026 ยท NCT07638410

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 21, 2026 ยท NCT07629960

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07705334

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 15, 2026 ยท NCT06263088

Evaluating Novel Therapies in ctDNA Positive GI Cancers

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 14, 2026 ยท NCT05482516

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 14, 2026 ยท NCT05059444

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Recruiting
Ages 18 to 50 ยท All sexes ยท Updated Sep 11, 2026 ยท NCT06202183

Resilience and Equity in Aging, Cancer, and Health (REACH)

Recruiting
Ages 65 and older ยท All sexes ยท Updated Sep 10, 2026 ยท NCT04674267

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.